Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36235004)
Watch
English
Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
main subject
monoclonal antibody
1 reference
based on heuristic
inferred from title
author name string
Mark R Albertini
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
Jacquelyn A Hank
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
Paul M Sondel
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
publication date
1 January 2005
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
published in
Cancer chemotherapy and biological response modifiers
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
volume
22
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
page(s)
789-797
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
cites work
Gangliosides of human melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-level expression of chimeric antibodies using adapted cDNA variable region cassettes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0921-4410%2804%2922037-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0921-4410(04)22037-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
PubMed publication ID
16110641
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16110641
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16110641%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit